Related Experiment Video
Updated: May 7, 2026

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
Published on: April 21, 2018
Paralysis efficiency (PD50) scales linearly with lethality (LD50) in spider venoms
Keith Lyons1,2,3, Dayle Leonard2, Leona McSharry2
1Macroecology Lab, School of Natural Sciences, Ryan Institute, University of Galway, H91 TK33, Galway, Ireland.
None:
Historically, venom potencies have been assessed using measures of lethality, such as the median lethal dose (LD50). However, venoms may be selected primarily for their ability to rapidly incapacitate rather than cause mortality, meaning LD50 may not capture the efficacy of venoms in an ecological and evolutionary context. To capture this context, recent studies have adapted measures that assess venoms' ability to rapidly incapacitate, such as the median paralysis dose (PD50). However, while PD50 values are expected to provide a more proximate assessment of ecological variation in venom potency, it is unknown whether historically available LD50 values are still useful proxies of ecologically relevant potency or whether they capture independent axes of venom variation. Here, we test the relationship between LD50 and PD50 in spider venoms by experimentally estimating LD50 and PD50 for 12 species and collating additional potency data for 46 species retrieved from the literature, producing a dataset of 55 species spanning 26 families when combined. We observed a linear isometric relationship between LD50 and PD50, showing these potency measures are both strongly correlated, with an increase in paralysis efficiency associated with a similar increase in lethality. Our results suggest that due to the correlation between functional aspects of venom potency, paralysis and lethality, historically available LD50 values may be used to compare general venom potencies in spiders, provided that they are based on the same prey model.
Related Concept Videos
Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
Pharmacokinetic–Pharmacodynamic Relationship: Intensity of Dose-Effect Relationship
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Dose-Response Relationship: Potency and Efficacy
Depolarizing Blockers: Pharmocokinetics
Pharmacodynamic Models: Logarithmic Concentration–Effect Model

